Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GammaPlus and I3 (International Isotopes) agree PET (Positron Emission Tomography) chemicals link:

This article was originally published in Clinica

Executive Summary

International Isotopes (I3) of Denton, Texas, has formed a joint venture with Austin-based GammaPlus to manufacture and distribute radiopharmaceuticals used in Positron Emission Tomography (PET). The new company, GammaPlus DFW, will distribute short-lived radiopharmaceuticals, including Fluorodeoxyglucose F-18, in Texas and other selected cities in the US. F-18 is widely used in PET whole body scans of patients with newly-diagnosed cancers, especially those of the breast and lung.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel